159 related articles for article (PubMed ID: 8597260)
1. Studies on selectin-carbohydrate interactions.
Jacob GS; Welply JK; Scudder PR; Kirmaier C; Abbas SZ; Howard SC; Keene JL; Schmuke JJ; Broschat K; Steininger C
Adv Exp Med Biol; 1995; 376():283-90. PubMed ID: 8597260
[TBL] [Abstract][Full Text] [Related]
2. Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells.
Welply JK; Abbas SZ; Scudder P; Keene JL; Broschat K; Casnocha S; Gorka C; Steininger C; Howard SC; Schmuke JJ
Glycobiology; 1994 Jun; 4(3):259-65. PubMed ID: 7524825
[TBL] [Abstract][Full Text] [Related]
3. Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin.
Stroud MR; Handa K; Salyan ME; Ito K; Levery SB; Hakomori S; Reinhold BB; Reinhold VN
Biochemistry; 1996 Jan; 35(3):770-8. PubMed ID: 8547257
[TBL] [Abstract][Full Text] [Related]
4. Higher-affinity oligosaccharide ligands for E-selectin.
Nelson RM; Dolich S; Aruffo A; Cecconi O; Bevilacqua MP
J Clin Invest; 1993 Mar; 91(3):1157-66. PubMed ID: 7680663
[TBL] [Abstract][Full Text] [Related]
5. In vivo ligand specificity of E-selectin binding to multivalent sialyl Lewisx N-linked oligosaccharides.
Thomas VH; Yang Y; Rice KG
J Biol Chem; 1999 Jul; 274(27):19035-40. PubMed ID: 10383404
[TBL] [Abstract][Full Text] [Related]
6. Multivalent sialyl Lewis x ligands of definite structures as inhibitors of E-selectin mediated cell adhesion.
Stahn R; Schäfer H; Kernchen F; Schreiber J
Glycobiology; 1998 Apr; 8(4):311-19. PubMed ID: 9499378
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of the dynamic strength of the sialyl Lewis X--selectin interaction.
Zhang X; Bogorin DF; Moy VT
Chemphyschem; 2004 Feb; 5(2):175-82. PubMed ID: 15038277
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a new nanomolar saccharide inhibitor of lymphocyte adhesion: different polylactosamine backbones present multiple sialyl Lewis x determinants to L-selectin in high-affinity mode.
Renkonen O; Toppila S; Penttilä L; Salminen H; Helin J; Maaheimo H; Costello CE; Turunen JP; Renkonen R
Glycobiology; 1997 Jun; 7(4):453-61. PubMed ID: 9184825
[TBL] [Abstract][Full Text] [Related]
9. Structure-function studies on selectin carbohydrate ligands. Modifications to fucose, sialic acid and sulphate as a sialic acid replacement.
Brandley BK; Kiso M; Abbas S; Nikrad P; Srivasatava O; Foxall C; Oda Y; Hasegawa A
Glycobiology; 1993 Dec; 3(6):633-41. PubMed ID: 7510548
[TBL] [Abstract][Full Text] [Related]
10. Single amino acid residues in the E- and P-selectin epidermal growth factor domains can determine carbohydrate binding specificity.
Revelle BM; Scott D; Beck PJ
J Biol Chem; 1996 Jul; 271(27):16160-70. PubMed ID: 8663282
[TBL] [Abstract][Full Text] [Related]
11. Fucosylation of disaccharide precursors of sialyl LewisX inhibit selectin-mediated cell adhesion.
Sarkar AK; Rostand KS; Jain RK; Matta KL; Esko JD
J Biol Chem; 1997 Oct; 272(41):25608-16. PubMed ID: 9325281
[TBL] [Abstract][Full Text] [Related]
12. Binding of sialyl Lewis x to E-selectin as measured by fluorescence polarization.
Jacob GS; Kirmaier C; Abbas SZ; Howard SC; Steininger CN; Welply JK; Scudder P
Biochemistry; 1995 Jan; 34(4):1210-7. PubMed ID: 7530048
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a specific ligand for P-selectin on myeloid cells. A minor glycoprotein with sialylated O-linked oligosaccharides.
Norgard KE; Moore KL; Diaz S; Stults NL; Ushiyama S; McEver RP; Cummings RD; Varki A
J Biol Chem; 1993 Jun; 268(17):12764-74. PubMed ID: 7685350
[TBL] [Abstract][Full Text] [Related]
14. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation.
Nelson RM; Cecconi O; Roberts WG; Aruffo A; Linhardt RJ; Bevilacqua MP
Blood; 1993 Dec; 82(11):3253-8. PubMed ID: 7694675
[TBL] [Abstract][Full Text] [Related]
15. L-selectin ligands in rat high endothelium: multivalent sialyl Lewis x glycans are high-affinity inhibitors of lymphocyte adhesion.
Toppila S; Lauronen J; Mattila P; Turunen JP; Penttilä L; Paavonen T; Renkonen O; Renkonen R
Eur J Immunol; 1997 Jun; 27(6):1360-5. PubMed ID: 9209485
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of natural protein-associated carbohydrate ligands for E-selectin.
Patel TP; Goelz SE; Lobb RR; Parekh RB
Biochemistry; 1994 Dec; 33(49):14815-24. PubMed ID: 7527659
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a tetravalent sialyl Lewis x glycan, a high-affinity inhibitor of L-selectin-mediated lymphocyte binding to endothelium.
Seppo A; Turunen JP; Penttilä L; Keane A; Renkonen O; Renkonen R
Glycobiology; 1996 Jan; 6(1):65-71. PubMed ID: 8991511
[TBL] [Abstract][Full Text] [Related]
18. An sLex-deficient variant of HL60 cells exhibits high levels of adhesion to vascular selectins: further evidence that HECA-452 and CSLEX1 monoclonal antibody epitopes are not essential for high avidity binding to vascular selectins.
Wagers AJ; Stoolman LM; Craig R; Knibbs RN; Kansas GS
J Immunol; 1998 May; 160(10):5122-9. PubMed ID: 9590264
[TBL] [Abstract][Full Text] [Related]
19. Selectin ligands on human melanoma cells.
Miller N; Vile RG; Hart IR
Glycoconj J; 1996 Feb; 13(1):33-43. PubMed ID: 8785485
[TBL] [Abstract][Full Text] [Related]
20. Structure-function analysis of P-selectin-sialyl LewisX binding interactions. Mutagenic alteration of ligand binding specificity.
Revelle BM; Scott D; Kogan TP; Zheng J; Beck PJ
J Biol Chem; 1996 Feb; 271(8):4289-97. PubMed ID: 8626776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
